Biomedical Engineering Reference
In-Depth Information
47. Goodman RM, Yergin BM, Landa JF, Golivanux MH, Sackner MA. Rela-
tionship of smoking history and pulmonary function tests to tracheal mucous
velocity in nonsmokers, young smokers, ex-smokers, and patients with chronic
bronchitis. Am Rev Respir Dis 1978; 117(2):205-214.
48. Agnew JE, Little F, Pavia D, Clarke SW. Mucus clearance from the airways in
chronic bronchitis-smokers and ex-smokers. Bull Eur Physiopathol Respir
1982; 18(3):473-484.
49. van der Schans CP, Piers DA, Beekhuis H, Koeter GH, van der Mark TW,
Postma DS. Effect of forced expirations on mucus clearance in patients with
chronic airflow obstruction: effect of lung recoil pressure. Thorax 1990;
45(8):623-627.
50. Ericsson CH, Svartengren K, Svartengren M, Mossberg B, Philipson K,
Blomquist M, et al. Repeatability of airway deposition and tracheobronchial
clearance rate over three days in chronic bronchitis. Eur Respir J 1995;
8(11):1886-1893.
51. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br
Med J 1977; l(6077):1645-1648.
52. Kauffmann F, Drouet D, Lellouch J, Brille D. Twelve years spirometric
changes among Paris area workers. Int J Epidemiol 1979; 8(3):201-212.
53. Higgins MW, Keller JB, Becker M, Howatt W, Landis JR, Rotman H, et al.
An index of risk for obstructive airways disease. Am Rev Respir Dis 1982;
125(2):144-151.
54. Ebi-Kryston KL. Respiratory symptoms and pulmonary function as
predictors of 10-year mortality from respiratory disease, cardiovascular dis-
ease, and all causes in the Whitehall Study. J Clin Epidemiol 1988; 41(3):
251-260.
55. Wiles FJ, Hnizdo E. Relevance of airflow obstruction and mucus hypersecre-
tion to mortality. Respir Med 1991; 85(l):27-35.
56. Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruc-
tion in chronic obstructive lung disease. N EngI J Med 1968; 278(25):
1355-1360.
57. Annesi I, Kauffmann F. Is respiratory mucus hypersecretion really an inno-
cent disorder? A 22-year mortality survey of 1061 working men. Am Rev
Respir Dis 1986; 134:688-693.
58. Vollmer WM, McCamant LE, Johnson LR, Buist AS. Respiratory symptoms,
lung function, and mortality in a screening center cohort. Am J Epidemiol
1989; 129(6):1157-1169.
59. Speizer FE, Fay ME, Dockery DW, Ferris BG Jr. Chronic obstructive
pulmonary disease mortality in six U.S. cities. Am Rev Respir Dis 1989;
140(3 Pt 2):S49-S55.
60. Vestbo J, Rasmussen FV. Respiratory symptoms and FEV1 as predictors of
hospitalization and medication in the following 12 years due to respiratory
disease. Eur Respir J 1989; 2(8):710-715.
61. Vestbo J, Knudsen KM, Rasmussen FV. The value of mucus hypersecretion
as a predictor of mortality and hospitalization. An 11-year register based
follow-up study of a random population sample of 876 men. Respir Med
1989; 83(3):207-211.
